HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Arterial blood gases study in patients with stable chronic obstructive pulmonary disease in accordance with spirometric values]

AbstractBACKGROUND AND OBJECTIVE: The aim of this study was to evaluate the need to assess arterial blood gases in patients with stable chronic obstructive pulmonary disease (COPD) in accordance with spirometric values. PATIENTS AND METHOD: Transverse study in stable COPD patients with spirometry and pulse oximetry assessment. Specific exclusion criteria were: diagnosis of asthma, sleep apnea syndrome or respiratory failure not due to COPD. Diagnostic of respiratory failure was established when pulse oximetry saturation was < or = 92%; we evaluated the best predicted FEV1 cut-off value. RESULTS: 467 patients (age = 64 [8] yr) were evaluated. FEV1 was 44 (14) % predicted. Two patients (1.5%) with FEV1 > 50 % and 29 patients (23.6%) with FEV1 between 41 and 50% had respiratory failure. Sensitivity (0.98) and rate of false-negative (0.98) at a cut-off of 50% predicted value FEV1 was superior to sensitivity (0.75%) and rate of false-negative (0.87) at a cut-off of 40% predicted value FEV1. CONCLUSIONS: In stable COPD patients, the rate of respiratory failure increases when the predicted value FEV1 is below 50%. Therefore, we recommend this spirometric cut-off to evaluate arterial blood gases.
AuthorsJosé Fernández Guerra, José María García Jiménez, Emilio Perea-Milla López, José Joaquín Cebrián Gallardo, Elena Mora Ruiz, Luis Felipe Moreno Arrastio (Affiliation: Unidad de Neumología, Hospital Costa del Sol, Marbella, Málaga, España. jfguerra at hcs.es)
JournalMedicina clínica (Med Clin (Barc)) Vol. 127 Issue 3 Pg. 90-2 (Jun 17 2006) ISSN: 0025-7753 [Print] Spain
Vernacular TitleGasometría arterial en pacientes con enfermedad pulmonar obstructiva crónica estable según los valores de la espirometría.
PMID16827998 (Publication Type: English Abstract, Journal Article)
Topics
  • Aged
  • Female
  • Forced Expiratory Volume
  • Humans
  • Male
  • Middle Aged
  • Oximetry
  • Predictive Value of Tests
  • Pulmonary Disease, Chronic Obstructive (blood, physiopathology)
  • Spirometry

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD